12 research outputs found
Faculty Opinions recommendation of Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics.
No full textFaculty Opinions recommendation of Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study.
No full textFaculty Opinions recommendation of Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia.
No full textFaculty Opinions recommendation of DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.
No full textFaculty Opinions recommendation of The genomic landscape of pediatric acute lymphoblastic leukemia.
No full textFaculty Opinions recommendation of Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
No full textFaculty Opinions recommendation of Decrease post-transplant relapse using donor-derived expanded NK-cells.
No full textFaculty Opinions recommendation of Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
No full textFaculty Opinions recommendation of Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes.
No full textFaculty Opinions recommendation of Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children.
No full text
